MELBOURNE, Australia, Jan. 14, 2026 /PRNewswire/ — Rhythm Biosciences Ltd (‘RHY‘, the ‘Company‘ or the ‘Group‘) (ASX: RHY), a transformative, predictive cancer diagnostics technology company is pleased to announce the commercial launch of its updated geneType^TM Colorectal Cancer (CRC) Risk Assessment clinical test (“geneType^TM CRC”), a significant advancement in personalised cancer risk prediction. The updated test incorporates additional clinical and lifestyle risk factors alongside the established 140-SNP polygenic risk score (PRS), delivering improved predictive accuracy across both genders and a wider age range.

The enhanced test is designed to support earlier identification of individuals at elevated risk of colorectal cancer, enabling more targeted screening pathways and complementing Rhythm’s ColoSTAT® blood-based CRC detection test.

Validation data for the updated model has been recently published in the peer-reviewed journal PLOS ONE (Dite GS, et al. 2025), demonstrating improved predictive performance compared to traditional approaches.

Evidence suggests that approximately 50% of colorectal cancer cases could be prevented through healthy lifestyle modifications. By incorporating lifestyle risk factors known to contribute to disease risk, the enhanced geneType^TM CRC test aims to identify a broader cohort of at-risk individuals who may benefit from earlier intervention and monitoring.

Key Clinical Applications

The enhanced geneType^TM CRC Risk Assessment test has several important use-cases for this innovative new clinical test:

1. Improved risk stratification across both genders, with particular benefits for identifying higher-risk women.
2. Identification of younger adults at risk of early-onset colorectal cancer, supporting earlier screening interventions.
3. Potential to encourage greater participation in bowel cancer screening programs by providing personalised risk insights.

In Australia, compliance with recommended bowel cancer screening programs remains below 50%. Individuals classified as higher risk using the geneType^TM CRC test may be candidates for closer clinical monitoring through colonoscopy, FIT testing, or Rhythm’s blood-based CRC detection test, ColoSTAT®. “The enhanced geneType^TM CRC test strengthens our ability to identify individuals at elevated risk earlier, supporting more targeted screening and complementing ColoSTAT’s® role in colorectal cancer detection.” said Dr Erika Spaeth, Director of Clinical Affairs at Rhythm.

About Rhythm Biosciences

Rhythm Biosciences Ltd (ASX: RHY) is an Australian innovative, medical diagnostics company aimed at delivering simple, affordable blood tests for accurate and early detection of cancers. Rhythm is focused on improving patient outcomes through detection at the earliest possible stage, reducing the global burden of cancer, and saving lives. Rhythm Biosciences is committed to working with likeminded global partners to achieve commercialisation and distribution of these simple solutions. The company was founded in 2017 and is headquartered in Melbourne, Australia. For more information, visit rhythmbio.com and follow the company on LinkedIn and X.

Source

MUMBAI, India and DALLAS, Jan. 14, 2026 /PRNewswire/ — Firstsource Solutions Limited (NSE: FSL) (BSE: 532809), a leading global provider of business management services and an RP-Sanjiv Goenka Group company, today announced the acquisition of TeleMedik, a Puerto Rico based pioneer in the development and implementation of technological solutions. The acquisition significantly strengthens Firstsource’s end-to-end clinical and utilization management capabilities, expands its footprint across payer-provider networks, and further enriches the company’s fully integrated and differentiated Business Process as a Service (BPaaS++) offering for health plan clients.

As health plans face higher utilization rates and rising financial burdens, the need for cost containment solutions is greater than ever. This, combined with the shift to value-based models requiring more personalized and outcome-focused care, has created a pivotal turning point where health plans are seeking digital solutions to advance capabilities across care coordination, member engagement, and data integration while retaining operational efficiencies.

By integrating digital and generative AI capabilities with clinical operations and utilization management into a unified service model, Firstsource has become a key partner for health plans looking to modernize the full medical management lifecycle—from intake and authorization through care coordination, clinical intervention, and ongoing member engagement without significant in-house investment. The acquisition combines Firstsource’s market-leading AI and automation capabilities with TeleMedik’s operational footprint in Puerto Rico and around the U.S. to help more payers improve quality, reduce administrative costs, and enhance member and provider experiences.

Dr. Sanjiv Goenka, Chairman of RPSG Group and Firstsource, said, “Firstsource remains committed to driving innovation and disruption in the healthcare space with intelligent automation and emerging technologies. Our company has built a significant presence in the U.S. healthcare space as well as an unmatched digital offering, and this strategic acquisition further elevates our capabilities and amplifies our reach across the industry. We welcome TeleMedik to the Firstsource team and look forward to collaborating on achieving greater improvements and efficiencies for payers, providers, and members alike.”

Dr. Joaquín Fernández-Quintero, President & CEO, TeleMedik Group, said, “As an organization with a digital-first mentality, we have worked hard to bring the latest innovations to our members and providers in Puerto Rico and around the U.S. We look forward to joining the Firstsource family and leveraging the company’s global reach, deep technology investments, and expanded delivery capabilities so that together we can best serve our health plan clients and the greater healthcare industry.”

This acquisition will further strengthen Firstsource’s offerings for health plans by:

• Deepening its access to the U.S. payer-provider ecosystem by adding strong relationships and operational presence, especially in Puerto Rico, providing a differentiated delivery and clinical services platform ideally suited to support the rapid growth of Medicaid, Medicare Advantage, and dual-eligible populations, including Spanish-speaking and underserved communities.
• Reducing operational risk and ensuring continuity while enabling Firstsource to deliver more enhanced capabilities in Utilization Management (UM), Care Management (CM), Disease Management (DM), and Population Health.
• Driving significant improvements in core administration and UM efficiency with combined technology stacks to enhance speed-to-proficiency for new operations, improve quality, and reduce costs for clients.

The acquisition of TeleMedik significantly enhances Firstsource’s clinical and utilization management capabilities across the full medical management lifecycle. Together, the combined organization will support health plans with integrated clinical review, prior authorization, care and disease management, population health, and telemedicine-enabled interventions—delivered through a unified operating model that improves speed to decision, clinical consistency, and member outcomes while reducing administrative burden.

About Firstsource
Firstsource Solutions Limited, an RP-Sanjiv Goenka Group company (NSE: FSL) (BSE: 532809) (Reuters: FISO.BO) (Bloomberg: FSOL:IN), is a global leader providing transformational solutions and services spanning the customer lifecycle across Healthcare, Banking and Financial Services, Communications, Media and Technology, Retail, and other diverse industries. With a global footprint across US, UK, India, Philippines, Mexico, Romania, Turkey, Trinidad & Tobago, South Africa, and Australia, they ‘make it happen’ for our clients, solving their biggest challenges with hyper-focused, domain-centered teams and cutting-edge tech, data, and analytics. Firstsource’s inch-wide, mile-deep practitioners work collaboratively, leveraging UnBPO™ – their differentiated approach to reimagining traditional outsourcing – to deliver real-world, future-focused solutions that drive speed, scale, and smarter decision, turning transformation into tangible results for clients. (www.firstsource.com)

Source

SHENZHEN, China, Jan. 13, 2026 /PRNewswire/ — ROE Visual, a globally recognised leader in LED display technology for live events, touring, broadcast, and installation, is proud to announce its 20th anniversary in 2026, celebrated under the theme “Beyond Stages. Passion On.” Since its founding in 2006 by Jason Lu as Radiant Opto Electronics Technology in Shenzhen, the company has continually redefined visual experiences and set new benchmarks for LED innovation.

Over two decades, ROE Visual has grown from a small, pioneering team into a global force, consistently delivering high-performance LED solutions to creatives, designers, technicians, and production professionals worldwide. From early breakthroughs such as the LINX line and the Magic Cube series to iconic products like Black Pearl, Carbon, and the innovative Topaz platforms, ROE Visual has shaped how audiences experience live visual storytelling. 

“As we approach this milestone, we see it not just as a celebration of time passed, but as an opportunity to renew our drive for innovation and deepen the partnerships that shape our industry,” said Jason Lu. “Our focus remains on creating meaningful solutions and growing alongside our community. Together, we’ll continue pushing the boundaries of visual technology and bringing bold ideas to life.”

ROE Visual will kick off its anniversary celebrations at Integrated Systems Europe (ISE) 2026 in Barcelona (3–6 February). Throughout the year, a series of anniversary events, product showcases, and partner collaborations will highlight both the company’s heritage and future direction, bringing the ROE Visual story to audiences across the globe.

Looking ahead, ROE Visual reaffirms its commitment to supporting the evolution of live events, broadcast environments, virtual production stages, and fixed installations with LED platforms that blend performance, reliability, and creative flexibility.

“For us, the future of LED displays is not about chasing trends, but about enabling creativity under real conditions,” said Grace Kuo, CSO at ROE Visual. “This 20-year journey of success is a shared one, made possible by our valued clients, partners, and every dedicated ROE team member. Whether it’s a touring show, a permanent installation, or a hybrid digital performance, the expectation is the same: absolute reliability, visual precision, and flexibility. At ROE Visual, we believe visual excellence is more than technology—it’s emotion. We are passionate about creating moments of wonder that bring people together.”

More information: https://www.roevisual.com/en/roe-visual-celebrates-20-years-of-pioneering-led-technology

CONTACT:
marketing@roevisual.com
janice@roevisual.com
viki.yang@roevisual.com
Kathy.xia@roevisual.com

Source

Accelerates growth with new signings in Seoul and Busan

SINGAPORE, Jan. 13, 2026 /PRNewswire/ — Wyndham Hotels & Resorts is stepping up its expansion in South Korea, opening its first managed hotel and adding two new development projects as it seeks to build scale in a market rebounding faster than much of Northeast Asia.

The company recently opened the 529-room Wyndham Goseong Gangwon, near Seoraksan National Park, and has signed agreements for Howard Johnson by Wyndham Seoul, expected to open in 2028, and Wyndham Busan, slated for 2030.

Wyndham’s expansion comes as South Korea’s tourism sector continues to rebound, supported by resilient domestic travel and a steady recovery in international arrivals. According to the Korea Tourism Organization, the country recorded 15.821 million inbound visitors between January and October, a 15.2% increase from a year earlier. Industry executives expect international demand to continue improving into 2025, supporting increased investment in branded accommodation across urban and resort markets.

“South Korea’s booming tourism market presents a compelling opportunity for Wyndham, which is why we’re focused on strategic expansion and strengthening our presence through high-caliber additions like Wyndham Goseong, Gangwon. With global scale, an industry-leading loyalty platform, and deep local expertise, Wyndham has a proven record of helping owners not only drive performance, but generate long-term value while delivering exceptional guest experiences.”

— Ben Schumacher, Regional Vice President, Operations, APAC, Wyndham Hotels & Resorts

Wyndham Goseong, Gangwon: A Coastal Retreat for Relaxation and Events

The opening of Wyndham Goseong, Gangwon marks Wyndham’s first managed hotel in South Korea and a key milestone in the Company’s local operations. Located adjacent to Bongpo Beach and Seoraksan National Park, the 529-room, ocean-view property is designed to serve leisure travelers, families, and MICE groups.

Over the past two years, Wyndham has expanded its footprint in South Korea through new brands and operating models, including the introduction of Wyndham Grand in 2023 and more recently, Trademark Collection by Wyndham in 2024. These additions build on an established portfolio of 30 hotels with more than 9,200 rooms across brands such as Days Inn^®, Howard Johnson^®, Ramada Plaza^®, Ramada^®, Ramada Encore^®, Ramada Hotel & Suites^®, Wyndham Grand^® and Trademark Collection^®, enabling Wyndham to serve diverse traveler segments while supporting owners with scalable, globally recognized brands.

Source